Trond Stokke

10.4k total citations · 1 hit paper
164 papers, 5.3k citations indexed

About

Trond Stokke is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Trond Stokke has authored 164 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Molecular Biology, 49 papers in Oncology and 29 papers in Cancer Research. Recurrent topics in Trond Stokke's work include DNA Repair Mechanisms (29 papers), Cancer-related Molecular Pathways (24 papers) and Lymphoma Diagnosis and Treatment (16 papers). Trond Stokke is often cited by papers focused on DNA Repair Mechanisms (29 papers), Cancer-related Molecular Pathways (24 papers) and Lymphoma Diagnosis and Treatment (16 papers). Trond Stokke collaborates with scholars based in Norway, United States and Germany. Trond Stokke's co-authors include Harald B. Steen, Erik Boye, Erlend B. Smeland, Paula M. De Angelis, Heidi Kiil Blomhoff, Debbie Hege Svendsrud, Anne Kallioniemi, Kirsten Skarstad, Olli Kallioniemi and Joe W. Gray and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Trond Stokke

163 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization.

1994 637 citations Trond Stokke et al. profile →

Peers

Countries citing papers authored by Trond Stokke

Since Specialization

Citations

This map shows the geographic impact of Trond Stokke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trond Stokke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trond Stokke more than expected).

Fields of papers citing papers by Trond Stokke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trond Stokke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trond Stokke. The network helps show where Trond Stokke may publish in the future.

Co-authorship network of co-authors of Trond Stokke

This figure shows the co-authorship network connecting the top 25 collaborators of Trond Stokke. A scholar is included among the top collaborators of Trond Stokke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trond Stokke. Trond Stokke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MRI Distinguishes Tumor Hypoxia Levels of Different Prognostic and Biological Significance in Cervical Cancer 2020 ·Cancer Research ·(unknown), Tord Hompland, Christina S. Fjeldbo, (unknown), (unknown), Eva‐Katrine Aarnes, (unknown), Kjersti V. Lund, (unknown), Gunnar B. Kristensen, Trond Stokke, Heidi Lyng	33
2	Selective Killing of Activated T Cells by 5-Aminolevulinic Acid Mediated Photodynamic Effect: Potential Improvement of Extracorporeal Photopheresis 2020 ·Cancers ·(unknown), Petras Juzenas, Morten P. Oksvold, (unknown), Toril Holien, Eidi Christensen, Trond Stokke, Mouldy Sioud, Qian Peng	11
3	Cell Cycle Analysis and Relevance for Single‐Cell Gating in Mass Cytometry 2020 ·Cytometry Part A ·(unknown), (unknown), Monica Bostad, Kanutte Huse, Trond Stokke	15
4	¹⁷⁷Lu-Lilotomab Satetraxetan Has the Potential to Counteract Resistance to Rituximab in Non-Hodgkin Lymphoma 2020 ·Journal of Nuclear Medicine ·(unknown), Sebastian Patzke, Anne Hansen Ree, Trond Stokke, (unknown), Brian Middleton, Jostein Dahle, (unknown)	5
5	A CEP104-CSPP1 Complex Is Required for Formation of Primary Cilia Competent in Hedgehog Signaling 2019 ·Cell Reports ·Kari‐Anne M. Frikstad, Elisa Molinari, Marianne Thoresen, Simon A. Ramsbottom, (unknown), Stef J.F. Letteboer, (unknown), Kay Oliver Schink, Trond Stokke, Stefan Geimer, Lotte B. Pedersen, Rachel H. Giles, Anna Akhmanova, Ronald Roepman, John A. Sayer, Sebastian Patzke	31
6	Three independent mechanisms for arrest in G₂after ionizing radiation 2011 ·Cell Cycle ·(unknown), Sebastian Patzke, (unknown), Caroline Stokke, Heidi Lyng, Paula M. De Angelis, Trond Stokke	30
7	Overexpression of human OGG1 in mammalian cells decreases ultraviolet A induced mutagenesis 2008 ·Cancer Letters ·Jostein Dahle, Gunnar Brunborg, Debbie Hege Svendsrud, Trond Stokke, Egil Kvam	22
8	Evaluation of the Binding of Radiolabeled Rituximab to CD20-Positive Lymphoma Cells: An In Vitro Feasibility Study Concerning Low-Dose-Rate Radioimmunotherapy with the α -Emitter ²²⁷ Th 2007 ·Cancer Biotherapy and Radiopharmaceuticals ·(unknown), Roy H. Larsen, Trond Stokke, Olav Kaalhus, Pål Kristian Selbo, Jostein Dahle	15
9	Garlic arrests MDA-MB-435 cancer cells in mitosis, phosphorylates the proapoptotic BH3-only protein BimEL and induces apoptosis 2005 ·British Journal of Cancer ·Troy C. Lund, Trond Stokke, Ole Olsen, Øystein Fodstad	20
10	Intratumor chromosomal heterogeneity in advanced carcinomas of the uterine cervix 2004 ·International Journal of Cancer ·Heidi Lyng, Marzieh Beigi, Debbie Hege Svendsrud, Odd Terje Brustugun, Trond Stokke, Gunnar B. Kristensen, Kolbein Sundfør, (unknown), Paula M. De Angelis	20
11	The Response of Malignant B Lymphocytes to Ionizing Radiation: Cell Cycle Arrest, Apoptosis and Protection against the Cytotoxic Effects of the Mitotic Inhibitor Nocodazole 2004 ·Radiation Research ·(unknown), Heidi Lyng, Trond Stokke	23
12	Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1 2003 ·Oncogene ·Anne Hansen Ree, Åse Bratland, (unknown), Trond Stokke, Øystein Fodstad	31
13	Associations between gene expressions in breast cancer and patient survival 2002 ·Human Genetics ·(unknown), (unknown), Trond Stokke, Eivind Hovig	70
14	A Comparison of Different Modes for the Detection of p53 Protein Accumulation a Study of Bladder Cancer 1997 ·Pathology - Research and Practice ·Sigrid Marie Kraggerud, Kari Dolven Jacobsen, (unknown), Trond Stokke, Ruth Holm, L Smedshammer, Anne‐Lise Børresen‐Dale, S.D. Fosså	14
15	Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX 1996 ·British Journal of Cancer ·(unknown), Kristian Berg, Trond Stokke, Qian Peng, (unknown)	157
16	P-glycoprotein is not expressed in a majority of colorectal carcinomas and is not regulated by mutant p53 in vivo 1995 ·British Journal of Cancer ·P. De Angelis, Trond Stokke, L Smedshammer, Ragnhild A. Lothe, Gustav Lehne, (unknown), (unknown)	35
17	Differential Effects of Interferon‐γ and Low Molecular Weight BCGF on Growth of Human B Lymphocytes; Interferon‐γ Prolongs the Increased c‐MYC mRNA Levels After Activation 1991 ·Scandinavian Journal of Immunology ·Jon Lømo, Erlend B. Smeland, Trond Stokke, Harald Holte, S. Funderud, (unknown)	3
18	Functional properties of CD19 B lymphocytes positively selected from buffy coats by immunomagnetic separation 1990 ·European Journal of Immunology ·Steinar Funderud, Björn Erikstein, (unknown), Kjell Nustad, Trond Stokke, Heidi Kiil Blomhoff, Harald Holte, Erlend B. Smeland	94
19	Levels of myc protein, as analyzed by flow cytometry, correlate with cell growth potential in malignant b‐cell lymphomas 1989 ·International Journal of Cancer ·Harald Holte, Trond Stokke, Erlend B. Smeland, Rosemary Watt, Heidi Kiil Blomhoff, Olav Kaalhus, Rolf Ohlsson	15
20	cAMP‐mediated growth inhibition of a B‐lymphoid precursor cell line Reh is associated with an early transient delay in G₂/M, followed by an accumulation of cells in G₁ 1988 ·Journal of Cellular Physiology ·Heidi Kiil Blomhoff, Rune Blomhoff, Trond Stokke, (unknown), (unknown), Erlend B. Smeland, Steinar Funderud, Tore Godal	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact